$0.87 0.02 (+1.84%)
2/13/2012 12:42 PM

BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Featured Broker Partners


Advertisement